Education
About Us
Working with TipRanks
Follow Us
Niagen Bioscience, Inc. (NAGE)
:NAGE
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 99.60M | $ 83.57M | $ 72.05M | $ 67.45M | $ 59.26M |
| Gross Profit | $ 61.59M | $ 50.78M | $ 42.80M | $ 41.49M | $ 35.27M |
| Operating Income | $ 7.73M | $ -5.60M | $ -18.63M | $ -27.07M | $ -19.85M |
| EBITDA | $ 9.21M | $ -3.89M | $ -16.74M | $ -25.45M | $ -18.34M |
| Net Income | $ 8.55M | $ -4.94M | $ -16.54M | $ -27.13M | $ -19.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 44.51M | $ 27.17M | $ 20.29M | $ 28.02M | $ 16.50M |
| Total Assets | $ 68.28M | $ 54.96M | $ 54.06M | $ 57.84M | $ 38.36M |
| Total Debt | $ 2.65M | $ 3.28M | $ 4.26M | $ 4.70M | $ 1.64M |
| Net Debt | $ -41.86M | $ -23.90M | $ -16.03M | $ -23.32M | $ -14.86M |
| Total Liabilities | $ 22.18M | $ 26.51M | $ 25.39M | $ 26.11M | $ 21.93M |
| Stockholders' Equity | $ 46.09M | $ 28.46M | $ 28.67M | $ 31.73M | $ 16.42M |
| Cash Flow | |||||
| Free Cash Flow | $ 11.95M | $ 6.97M | $ -15.43M | $ -24.57M | $ -10.74M |
| Operating Cash Flow | $ 12.11M | $ 7.12M | $ -15.10M | $ -24.16M | $ -10.60M |
| Investing Cash Flow | $ -143.00K | $ -143.00K | $ -334.00K | $ -409.00K | $ -165.00K |
| Financing Cash Flow | $ 5.37M | $ -90.00K | $ 7.65M | $ 36.09M | $ 8.65M |